Our Centre of Excellence embraces a holistic approach to guide and support cancer patients throughout their treatment journey. One of the pivotal aspects of our CoE is the implementation of Tumour Specific Electroporation Study. By utilising the Electroporation device system IQwave 3.0 CE, clinicians reduce the tumour size in cancer patients. The clinical study also evaluates the efficacy of the treatment, changes in patients’ immune response, and its impact on their quality of life. In partnership with AIIMS Jodhpur, our Centre of Excellence is committed to a patient-centred approach to cancer care. Our joint initiatives not only intend to reduce tumour sizes but also emphasise the importance of prioritising the holistic well-being of patients and supporting them in adhering to their treatment. Learn more: www.indiaswedenic.com #CancerCare #CoE #HolisticApproach #TumourSpecificElectroporation #IQwave3 #ClinicalStudy #PatientCentredCare #AIIMSJodhpur #CancerTreatment #QualityofLife #ImmuneResponse #HealthcareInnovation #MedicalResearch #PatientSupport #WellBeing #HolisticWellness #CancerResearch #InnovativeTreatment #ElectroporationStudy #CancerSupport #JointInitiatives #TreatmentJourney #MedicalPartnership #ClinicianCare #ReducingTumourSize #PatientAdherence #QualityHealthcare NITI Aayog Official Ministry of Health and Family Welfare, Government of India Business Sweden Atal Innovation Mission Official T-Hub Bioinnovation Centre, Bangalore Centre for Cellular and Molecular Platforms (C-CAMP) Sweden in Mumbai Sweden In India Startup India MeitY- nasscom Center of Excellence Embassy of Sweden Directorate General of Health Services MeitY Startup Hub AstraZeneca India AstraZeneca Dr. Sanjeev Panchal Dolly Berry Subhankar Basak, PhD Cecilia Oskarsson Dr Ajaykumar Sharma Pankaj Bhardwaj Dr. Anil Kukreja Dr. Shilpi Gupta Dixit Dr. Manjari Singh Harika Garapati 𝐀𝐧𝐤𝐢𝐭 𝐓𝐢𝐰𝐚𝐫𝐢 𝐊𝐔𝐋𝐃𝐄𝐄𝐏 𝐒𝐈𝐍𝐆𝐇
